Navigation Links
Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
Date:12/9/2010

"augments" protein levels in AAT deficient patients.   In the U.S. and Canada, PROLASTIN-C has replaced PROLASTIN, the leading augmentation therapy in North America for more than 20 years.  

Important Safety Information for PROLASTIN-C

The effect of augmentation therapy with any alpha(1)-proteinase inhibitor on pulmonary exacerbations and on the progression of emphysema in alpha(1)-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

PROLASTIN-C may contain trace amounts of IgA.  Patients with known antibodies to IgA, which can be present in patients with selective or severe IgA deficiency, have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions.  PROLASTIN-C is contraindicated in patients with antibodies against IgA.

The most common drug related adverse reactions during clinical trials in greater than or equal to 1% of subjects were chills, malaise, headache, rash, hot flush, and pruritus.  The most serious adverse reaction observed during the clinical studies with PROLASTIN-C was an abdominal and extremity rash in one subject.

PROLASTIN-C is made from human plasma. Products made from human plasma may carry a risk of transmitting infectious agents, e.g., viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

In the US, for additional information on PROLASTIN-C, please see full prescribing information at www.PROLASTIN.com.  You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

About Alpha(1)-Antitrypsin Deficiency

Alpha(1)-antitrypsin deficiency, also known as AAT deficiency or Alpha-1, is an inherited disorder that causes significant reduction in the naturally occurring protein alpha(1)-proteina
'/>"/>

SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
2. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
3. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
4. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
5. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
6. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
7. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
8. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
9. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
10. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
11. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)...  Lannett Company, Inc. (NYSE: LCI ) today ... Genuity 35th Annual Growth Conference on Wednesday, August 12, ... Hotel.  A webcast of the presentation ... encouraged to visit the web site at least 10 ... register, download and install any necessary software.  The presentation ...
(Date:7/30/2015)... 30, 2015  Cleave Biosciences today announced that ... granted the company a key patent providing the ... CB-5083. This newly issued patent, "Fused ... U.S. 9,062,026, allows for claims on the composition ... oral inhibitor of p97, a critical enzyme that ...
(Date:7/30/2015)... , July 30, 2015 Flexpoint Ford, a ... services sectors, today announced that it has entered into ... Bryan Stuart to form Kastle Therapeutics, LLC (Kastle).  ... , will focus on acquiring, developing and commercializing pharmaceuticals ... acquisition opportunities include select therapies already approved for marketing, ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
(Date:7/30/2015)... , ... July 30, 2015 , ... ... program at ATA’s 21st Annual Meeting and Tradeshow focused exclusively on telemedicine, telehealth ... 300 cutting-edge health care technology vendors, will take place May 14-17, 2016 in ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At ... and San Bernardino counties, today announced that Dr. Michael Demoratz, PhD, LCSW, CCM ... is a strong proponent of early access to palliative care services for the ...
(Date:7/30/2015)... TX (PRWEB) , ... July 30, 2015 , ... ... Grant Program and fourth annual Institute Scholar Program. In partnership with Patient Experience ... of patient experience, develop leaders on the front lines and throughout the experience ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma ... Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress ... King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston ... the annual All-Stars Summit. Google Partners is the platform for search marketing agencies ... full support and tools necessary to run successful search marketing campaigns. Google Partners ...
Breaking Medicine News(10 mins):Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2
... $14 million from the Centers for Disease Control and ... fight HIV/AIDS in eight countries that lack the large-scale ... $8 million of the grant will support the efforts ... of Health of Ethiopia and rural Jimma University, ...
... Cardiac Arrest,Association (SCAA) has appointed Chris Chiames as its ... join SCAA as we begin to implement our,strategic plan, ... goal of,eliminating preventable sudden cardiac arrest deaths (SCA) by ... Board of Directors.,"Advancements in medical technology and treatment can ...
... local nonprofit alcohol and,drug treatment agencies have formed ... the children of alcoholics and other drug addicts.,Recovery ... to produce a public awareness campaign, provide training ... is being,funded through a $145,000 grant from the ...
... Mice containing a mutated human gene implicated in autism ... the title characters traits in the movie Rain Man,? researchers ... study also shows how the mutation affects nerve function and ... the debilitating condition. , Its an attempt to replicate, as ...
... bigger toll than other chronic conditions , , FRIDAY, Sept. ... diseases, depression may well be the most disabling disease ... People with chronic physical diseases such as angina, arthritis, ... also suffer from depression, the team of international researchers ...
... Surface Offers Safe, ... Effective Alternative to Surgery, COLUMBUS, Ohio, Sept. ... world,s first physician on Wednesday, Aug.,29, to treat a common ... improves outcomes, speeds recovery and may minimize the risk of,complications. ...
Cached Medicine News:Health News:Tulane University to receive $14M for international HIV/AIDS program 2Health News:Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association 2Health News:Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program 2Health News:'Rain Man' mice provide model for autism 2Health News:Depression May Be World's Most Disabling Disease 2Health News:Depression May Be World's Most Disabling Disease 3Health News:Riverside First to Offer New Treatment for Peripheral Arterial Disease 2Health News:Riverside First to Offer New Treatment for Peripheral Arterial Disease 3
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
... Pro Resectoscope is based on the award ... enables the surgeon to perform TURis - ... working element, HF cable and electrodes, Olympus ... resection in saline, supporting both, standard TUR ...
... internal drainage from the ureteropelvic junction to ... for ease of placement and patient compliance. ... for repositioning and ease of removal. AQ® ... that when activated, attracts and holds water ...
... a PC-based ECG device that can ... and an innovative software. The system ... recording using a standard 12-lead setup ... The software includes two applications: Rest ...
Medicine Products: